CION Ameerpet
Sometimes lymphoma begins not in a lymph node but inside an organ — the stomach, brain, skin or bone. This guide explains what extranodal lymphoma is, how it shows up, and how CION's team diagnoses and treats extranodal NHL.
Extranodal lymphoma is lymphoma that starts in — or mainly involves — a tissue outside the lymph nodes. Lymphocytes, the white blood cells that lymphoma arises from, travel throughout the body, so lymphoma can begin almost anywhere lymphoid tissue exists. When it does not present in the usual way — a painless swollen node — but instead grows inside an organ, we call it extranodal.
The most common site is the gastrointestinal tract (stomach and bowel), but extranodal lymphoma is also found in the skin, the brain and spinal cord, bone, the testis, the lung, the thyroid and the tissues around the eye. When the disease is confined to one such site it is called primary extranodal lymphoma; when lymphoma in the nodes spreads to an organ it is called secondary extranodal involvement. The great majority are non-Hodgkin B-cell types — this is what people mean by extranodal NHL.
Because the tumour sits inside an organ, lymphoma outside lymph nodes often first looks like a non-cancer problem of that organ, which can delay the diagnosis. This guide explains the common sites and symptoms, how the diagnosis is confirmed, and how CION treats it. For the wider family of subtypes, see our Lymphoma hub, and for how plans are built, our Lymphoma Treatment in Hyderabad page.
The gastrointestinal tract is the most common extranodal site for non-Hodgkin lymphoma, and the stomach is the single most frequent organ involved. Roughly a quarter to a third of non-Hodgkin lymphomas arise at an extranodal site rather than in the lymph nodes. This is why persistent stomach symptoms that do not settle deserve proper endoscopic assessment rather than repeated courses of acid-suppressing medicine. (Source: patterns described in NCCN and ESMO non-Hodgkin lymphoma guidelines.)
Extranodal lymphoma is grouped by where it starts, because the site shapes the symptoms, the tests needed and the treatment. These are the sites seen most often.
| Site | How it often shows up | Common subtype family |
|---|---|---|
| Stomach & bowel | Indigestion, pain, fullness, bleeding, weight loss | DLBCL & MALT / marginal zone |
| Skin | Persistent patches, plaques or nodules | Cutaneous B- and T-cell lymphomas |
| Brain & spinal cord | Headache, weakness, seizures, personality change | Primary CNS lymphoma |
| Testis | Painless swelling of one testicle | Aggressive B-cell (DLBCL) |
| Thyroid | Rapidly enlarging neck mass | Marginal zone & DLBCL |
| Bone | Localised, persistent bone pain | Aggressive B-cell (DLBCL) |
This table is a general guide; presentations vary by individual. The exact subtype is confirmed on tissue, not predicted from the site alone. Subtype naming follows the WHO classification as referenced in NCCN and ESMO guidance.
Extranodal lymphoma can be the same cancer cell as nodal disease, but growing inside an organ changes several practical things.
Some extranodal lymphomas are driven by chronic infection. The classic example is MALT lymphoma of the stomach, which is closely linked to H. pylori — clearing the infection with antibiotics can, on its own, put an early gastric MALT lymphoma into remission.
Radiation and surgery near delicate structures — the eye, brain, bowel or testis — must be planned to spare healthy tissue. Precision radiation (IMRT) and careful, image-guided planning matter more when the tumour sits inside a functioning organ.
The brain, spinal cord and testis are "sanctuary sites" that ordinary drug therapy reaches poorly. Primary CNS lymphoma and testicular lymphoma therefore need treatment plans designed to penetrate or protect the central nervous system.
PET-CT and bone-marrow assessment stage most lymphomas, but extranodal disease often needs extra, site-specific tests — an MRI of the brain, an eye examination, or endoscopy — to map the true extent before treatment begins.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Just learned your lymphoma is in an organ rather than a node, want to understand your extranodal NHL subtype, or need a second opinion before treatment? CION's lymphoma team is here.
Because extranodal lymphoma grows inside an organ, its first symptoms usually reflect that organ rather than the swollen nodes people associate with lymphoma. This is exactly why it can be mistaken for a common, non-cancer problem. The pattern depends on the site:
Most of these symptoms have ordinary, non-cancer causes. But a symptom that is new, persistent and not settling — especially with weight loss or night sweats — deserves proper assessment. Speak to a CION lymphoma specialist if you have these signs or a confirmed diagnosis.
Confirming extranodal lymphoma — and pinning down its exact subtype — follows a step-by-step pathway set out in NCCN and ESMO guidelines. CION delivers the biopsy coordination, expert pathology, staging scans and review directly.
The diagnosis is made on a tissue sample, not on a scan alone. Depending on the site, this may be an endoscopic biopsy of the stomach, a skin biopsy, or an image-guided or surgical sample from a deeper organ. A specialist haematopathologist examines the tissue and runs immunohistochemistry and molecular tests — markers such as CD20 and, for aggressive B-cell disease, cell-of-origin testing — to name the exact subtype.
Once the subtype is known, staging maps how far the disease reaches. PET-CT is the workhorse for most lymphomas, and a bone-marrow examination is added when indicated. This tells the team whether the disease is truly confined to one extranodal site or is more widespread — which changes the treatment intensity.
Extranodal disease often needs extra tests tailored to the organ involved: an MRI of the brain and an eye examination for suspected CNS lymphoma, endoscopy for gastric disease, or testing for H. pylori where MALT lymphoma is suspected. Every case is then reviewed by CION's multidisciplinary tumour board before a plan is finalised.
A stomach lymphoma of the MALT (marginal zone) type linked to H. pylori infection is one of the few cancers that can respond to antibiotics alone: eradicating the bacterial infection puts many early gastric MALT lymphomas into lasting remission, as recognised in NCCN and ESMO guidance. It is a striking example of how the extranodal site — and its cause — can completely change the treatment. Read more on our MALT lymphoma page.
The plan depends on the subtype, the site and the stage. Every case is reviewed by CION's multidisciplinary tumour board first, and specific drug regimens are individualised — see our Lymphoma Treatment in Hyderabad page for how they are chosen. The main building blocks are:
Most B-cell extranodal lymphomas are treated with chemotherapy, often combined with an anti-CD20 monoclonal antibody (immunotherapy) when the tumour carries the CD20 marker. CION's medical oncology team delivers these directly. The number of cycles and the exact combination are set by the subtype and stage.
For localised extranodal disease, precision radiation can be highly effective — sometimes as the main treatment, sometimes after chemotherapy. CION delivers IMRT directly, shaping the beam to the involved organ while sparing nearby healthy tissue such as the eye, bowel or salivary glands.
Some subtypes respond to targeted therapy directed at specific pathways in the lymphoma cell. And where an infection is the driver — most notably H. pylori in gastric MALT lymphoma — treating that infection first can be the whole of early-stage therapy.
For aggressive subtypes such as DLBCL, or disease that returns (relapsed or refractory DLBCL), a stem-cell transplant or CAR-T cell therapy may be recommended. CION coordinates these through accredited partner facilities — they are not delivered in-house — while continuing to manage your overall care.
The outlook for extranodal lymphoma depends far more on the subtype and stage than on the fact that it is extranodal. Aggressive B-cell types such as DLBCL are potentially curable — across published series roughly 60–70% of people are alive at five years, and localised disease tends to do better (see DLBCL survival & prognosis). Indolent types such as marginal zone and MALT lymphoma are slow-growing and very treatable, though they can relapse over time — many people live well for years with an indolent lymphoma. Hodgkin lymphoma, which is rarely extranodal, carries around 80–90% survival in published data. These NCCN- and ESMO-referenced figures vary considerably by individual.
Depending on your exact diagnosis, these related pages may help: follicular lymphoma (and its transformation to aggressive disease), mantle cell lymphoma, and Burkitt lymphoma. To find the most experienced team, see our Best Lymphoma Doctors in Hyderabad and Best Lymphoma Hospital in Hyderabad pages.
Extranodal lymphoma carries a lot of nuance, and a second opinion is especially valuable in a few situations:
CION offers a dedicated, free written second-opinion service. You deserve a plan built around healing, not billing — with transparent costs explained up front. Request your free second opinion or call 18002028726.
Get a free written second opinion from CION's lymphoma tumour board — especially valuable if the exact subtype or the best next step for your extranodal site is uncertain.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Extranodal lymphoma is lymphoma that starts in — or mainly involves — an organ or tissue outside the lymph nodes, rather than in the nodes themselves. Lymphocytes travel throughout the body, so lymphoma can begin almost anywhere lymphoid tissue exists: the stomach and bowel, skin, brain and spinal cord, bone, testis, lung, thyroid or the tissue around the eye. When the disease is confined to one such site it is called primary extranodal lymphoma; when nodal disease also spreads to an organ it is called secondary extranodal involvement. Most extranodal lymphomas are non-Hodgkin B-cell types (extranodal NHL). The site of origin shapes the symptoms, the tests needed and the treatment, which is why an accurate diagnosis matters so much.
The cancer cell type can be the same; what differs is where it grows and how it shows up. Because extranodal lymphoma sits inside an organ, its first symptoms often mimic a non-cancer problem of that organ — stomach lymphoma can feel like an ulcer, brain lymphoma can look like a stroke, and skin lymphoma can resemble eczema. This can delay diagnosis. Extranodal sites also change the staging work-up and sometimes the treatment: some sites need extra imaging, some need protection of nearby organs during radiation, and a few — such as MALT lymphoma of the stomach — can respond to treating an underlying infection. The core principles of biopsy confirmation, staging and multidisciplinary planning stay the same as for nodal lymphoma.
The gastrointestinal tract is the most common extranodal site — stomach and bowel lymphoma can cause indigestion, pain, fullness, bleeding or unexplained weight loss (see gastrointestinal lymphoma). Skin lymphoma may appear as persistent patches, plaques or nodules. Primary CNS lymphoma in the brain can cause headaches, weakness, personality change or seizures. Lymphoma of the testis shows as a painless swelling; thyroid lymphoma as a rapidly enlarging neck mass; bone lymphoma as localised pain. General "B symptoms" — drenching night sweats, unexplained fever and weight loss — can occur with any site. Because these overlap with common benign conditions, a symptom that is new, persistent and not settling deserves proper assessment.
Diagnosis rests on a tissue biopsy from the affected organ — for example an endoscopic biopsy for stomach lymphoma, a skin biopsy, or an image-guided or surgical sample from a deeper site. A specialist haematopathologist examines the tissue and runs immunohistochemistry and molecular tests (markers such as CD20 and cell-of-origin) to pin down the exact subtype. Staging then maps how far the disease extends, usually with PET-CT and often a bone-marrow examination; site-specific scans such as MRI of the brain are added when relevant. NCCN and ESMO guidelines set out this pathway. CION delivers biopsy coordination, expert pathology, PET-CT staging and bone-marrow assessment, and reviews every case at a multidisciplinary tumour board before a plan is set.
Treatment is tailored to the subtype, the site and how far the disease has spread. The main tools are chemotherapy, immunotherapy with anti-CD20 monoclonal antibodies, targeted therapy and radiation (IMRT) — all delivered directly at CION. Some sites need special measures: a stomach MALT lymphoma linked to H. pylori may be treated first with antibiotics to clear the infection, while brain and testicular lymphoma need regimens that protect or reach the central nervous system. For aggressive or relapsed disease, stem-cell transplant or CAR-T cell therapy may be recommended and are coordinated through accredited partner facilities. Specific drug regimens are individualised — see our Lymphoma Treatment in Hyderabad page for how plans are built.
Many extranodal lymphomas respond very well to treatment, and some are highly curable — but the outlook depends heavily on the subtype, the site and the stage. Aggressive B-cell types such as DLBCL are potentially curable; across published series roughly 60–70% of people are alive at five years, and localised disease often does better. Indolent types such as marginal zone / MALT lymphoma are typically slow-growing and very treatable, though they can relapse over time. By contrast, Hodgkin lymphoma (which is rarely extranodal) carries around 80–90% survival in published data. These figures come from NCCN- and ESMO-referenced series and vary considerably by individual — your own outlook is best discussed with your specialist.
Almost always. The great majority of extranodal lymphomas are non-Hodgkin lymphoma (extranodal NHL), and most of those are B-cell types — for example DLBCL and the marginal-zone / MALT group. Hodgkin lymphoma occasionally involves an organ outside the nodes, but true primary extranodal Hodgkin lymphoma is rare. This is one reason getting the exact diagnosis right matters: the subtype, not just the location, drives the treatment plan and the expected outlook. If you want to understand the wider family of subtypes, our lymphoma hub and the DLBCL and follicular lymphoma pages give the fuller picture.
Browse our complete guide to lymphoma — symptoms, diagnosis, Hodgkin and non-Hodgkin subtypes, treatment, genetics, prognosis, survivorship and cost. Tap any topic to read more.